BMS 1611
Generic Name: entecavir
Pill imprint BMS 1611 has been identified as Baraclude 0.5 mg.
Baraclude is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy.
Baraclude 0.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Baraclude Images
- Generic Name:
- entecavir
- Imprint:
-
BMS
1611 - Strength:
- 0.5 mg
- Color:
- White
- Shape:
- Three-sided
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose monohydrate
microcrystalline cellulose
crospovidone
povidone
magnesium stearate
titanium dioxide
hypromelloses
polyethylene glycol 400
polysorbate 80
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-1611
Advertisement
More Baraclude resources
Search Again
